Morbidity of Vietnam veterans: multiple sclerosis and motor neurone disease in Vietnam veterans, supplementary report 3

Morbidity of Vietnam veterans: multiple sclerosis and motor neurone disease in Vietnam veterans, supplementary report 3

FREE

Phone, fax or email orders:

AIHW
Tel. 02 6244 1032
Fax 02 6244 1045
Email

Read the related media release.

View other publications by the same authors: AIHW & Commonwealth Department of Veterans' Affairs.

View other publications in the same subject area: Population health.

This report provides medical validations for two conditions of concern regarding the health of Vietnam veterans - multiple sclerosis and motor neurone disease. It is the third supplementary report to Morbidity of Vietnam Veterans: Volume 3 Validation Study and fulfils the recommendation in Volume 1 of the study, the survey of male veterans, that the reported rates of multipe sclerosis and motor neurone disease be validated. This report further extends the knowledge about the health of Vietnam veterans and their families.

Authored by AIHW & Commonwealth Department of Veterans' Affairs.

Published 25 May 2001; ISBN-13 978 1 74024 111 3; AIHW cat. no. PHE 31; 54pp.; FREE

Download free

Help with downloads

Full publication

Publication table of contents

  • Preliminary material
    • Title page and verso
    • Letter to the Minister
    • Contents
    • List of tables, figures and boxes
    • Acknowledgments
    • Executive summary (separate 99K PDF)
  • Sections
    1. Purpose, organisation and management
      •  1.1 Introduction and background
        • Objectives of the MS and MND study
      • 1.2 Study organisation and administration
        • Study Advisory Committee
        • Ethics Committee
        • Expert Neurologist Panel
        • Structure of the report
    2. Multiple sclerosis and motor neurone disease
      • 2.1 Multiple sclerosis
        • Epidemiology
        • Signs and symptoms
        • Diagnosis
      • 2.2 Motor neurone disease
        • Epidemiology
        • Signs and symptoms
        • Diagnosis
    3. Study design
      • 3.1 Study population
        • 'New veterans' and 'new conditions'
      • 3.2 Survey methods
        • Survey of veterans
        • Survey of general practitioners and hospitals
        • Survey of neurologists
        • Classification of clinical notes
        • Deaths of veterans
      • 3.3 Validation methodology
        • Recalculation of Australian community standards
        • Misallocation of conditions
        • Allocation of non-respondents and not able to be validated responses
    4. Results
      • 4.1 Survey response
        • Veterans
        • Doctors
        • Neurologists
      • 4.2 Validation of conditions
        • Panel classification results
        • Veterans' deaths since 1997
        • Validation of MS and MND in veterans
        • Impact of method of allocation of non-respondents and not able to be validated responses
        • 'New veterans' and 'new conditions'
      • 4.3 Conclusion
  • End matter
    • Appendixes
      • Appendix 1
      • Appendix 2
      • Appendix 3
      • Appendix 4
      • Appendix 5
        • El Escorial criteria
        • Rose criteria
    • References